Korean Circ J.  2015 May;45(3):210-215. 10.4070/kcj.2015.45.3.210.

The Association between Subclinical Hypothyroidism and Epicardial Adipose Tissue Thickness

• Belen E
• Degirmencioglu A
• Zencirci E
• Tipi FF
• Altun O
• Karakus G
• Helvaci A
• Zencirci A
• Kalaycioglu E

• KMID: 2389128
• DOI: http://doi.org/10.4070/kcj.2015.45.3.210

Abstract

BACKGROUND AND OBJECTIVES
Subclinical hypothyroidism (SH) is considered to be a potential risk factor for cardiovascular disease. Epicardial adipose tissue (EAT) thickness is also closely related to cardiovascular disorders. The aim of this study was to evaluate whether SH is associated with higher EAT thickness.
SUBJECTS AND METHODS
Fifty-one consecutive patients with SH and 51 healthy control subjects were prospectively enrolled into this trial. Thyroid hormone levels, lipid parameters, body mass index, waist and neck circumference, and EAT thickness measured by echocardiography were recorded in all subjects.
RESULTS
Mean EAT thickness was increased in the SH group compared to the control group (6.7+/-1.4 mm vs. 4.7+/-1.2 mm, p<0.001). EAT thickness was shown to be correlated with thyroid stimulating hormone level (r=0.303, p=0.002). Multivariate logistic regression analysis revealed that EAT thickness was independently associated with SH {odds ratio (OR): 3.87, 95% confidence interval (CI): 1.92-7.78, p<0.001; OR: 3.80, 95% CI: 2.18-6.62, p<0.001}.
CONCLUSION
Epicardial adipose tissue thickness is increased in patients with SH compared to control subjects, and this increase in EAT thickness may be associated with the potential cardiovascular adverse effects of SH.

Keyword

Cardiovascular diseases; Echocardiography; Epicardium; Hypothyroidism; Visceral adipose tissue

MeSH Terms

Adipose Tissue*
Body Mass Index
Cardiovascular Diseases
Echocardiography
Humans
Hypothyroidism*
Intra-Abdominal Fat
Logistic Models
Neck
Pericardium
Prospective Studies
Risk Factors
Thyroid Gland
Thyrotropin
Thyrotropin

Figure

• 

  Fig. 1 Epicardial adipose tissue thickness measurement by echocardiography in the parasternal long axis view.

Reference

1. Jones DD, May KE, Geraci SA. Subclinical thyroid disease. Am J Med. 2010; 123:502–504.

2. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012; 379:1142–1154.

3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001; 344:501–509.

4. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003; 88:2438–2444.

5. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010; 304:1365–1374.

6. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110:1245–1250.

7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–2752.

8. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007; 17:319–326.

9. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003; 11:304–310.

10. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008; 117:605–613.

11. Waring AC, Rodondi N, Harrison S, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol (Oxf). 2012; 76:911–918.

12. Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocr J. 2007; 54:71–76.

13. Ben-Noun L, Sohar E, Laor A. Neck circumference as a simple screening measure for identifying overweight and obese patients. Obes Res. 2001; 9:470–477.

14. Kahn R, Buse J, Ferrannini E, Stern M. American Diabetes Association. European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005; 28:2289–2304.

15. Castro JP, El-Atat FA, McFarlane SI, Aneja A, Sowers JR. Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003; 5:393–401.

16. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137:904–914.

17. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid. 2007; 17:625–630.

18. Duntas LH. Thyroid disease and lipids. Thyroid. 2002; 12:287–293.

19. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab. 2002; 87:1996–2000.

20. Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003; 18:146–153.

21. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007; 92:491–496.

22. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf). 2007; 67:265–269.

23. Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, O'Shea D. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women. Thyroid. 2007; 17:243–248.

24. Ashizawa K, Imaizumi M, Usa T, et al. Metabolic cardiovascular disease risk factors and their clustering in subclinical hypothyroidism. Clin Endocrinol (Oxf). 2010; 72:689–695.

25. Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003; 88:5163–5168.

26. Natale F, Tedesco MA, Mocerino R, et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr. 2009; 10:549–555.

27. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005; 2:536–543.

28. Unubol M, Eryilmaz U, Guney E, Akgullu C, Kurt Omurlu I. Epicardial adipose tissue in patients with subclinical hypothyroidism. Minerva Endocrinol. 2014; 39:135–140.

29. Asik M, Sahin S, Ozkul F, et al. Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf). 2013; 79:571–576.

30. Santos OC, Silva NA, Vaisman M, et al. Evaluation of epicardial fat tissue thickness as a marker of cardiovascular risk in patients with subclinical hypothyroidism. J Endocrinol Invest. 2014; [Epub ahead of print].